Position in NXL
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$7,367
-$750 QoQ
Shares Held
744
-4.2% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 20 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NXL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Kovack Advisors, Inc. holds $4,155,744 across 8 Medical Devices names. NXL ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
19,170 | $1,739,485 | |
| 2 | MDT |
Medtronic plc
|
13,914 | $1,088,492 | |
| 3 | SYK |
Stryker Corp
|
1,750 | $550,970 | |
| 4 | GEHC |
GE HealthCare Technologies Inc.
|
4,379 | $280,299 | |
| 5 | ARAY |
Accuray Inc
|
1,050,896 | $273,232 | |
| 6 | BFLY |
Butterfly Network, Inc.
|
22,383 | $188,464 | |
| 7 | QSI |
Quantum-Si Inc
|
31,000 | $27,435 | |
| 8 | NXL |
Nexalin Technology, Inc.
This page
|
744 | $7,367 |
All Filings in NXL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,367 | 22,325 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $8,117 | 23,325 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $433 | 23,325 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $307 | 10,050 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $330 | 10,050 | Shares | Sole | 2025-08-04 | |
| No filing history on record for this holder in this stock. | ||||||